Applications of Probiotics as a Functional Ingredient in Food and Gut Health

Snigdha Misra^1, , Debapriya Mohanty² and Swati Mohapatra³

¹Division of Nutrition and Dietetics, School of Health Sciences, International Medical University, 57000, Kuala Lumpur, Malaysia

²Research Associate, Institute of Life Sciences, 751023 Bhubaneswar, Odisha, India

³Department of Biotechnology, Amity University (AIMT), Noida 201313, Uttar Pradesh, India

Cite this paper:
Snigdha Misra, Debapriya Mohanty and Swati Mohapatra. Applications of Probiotics as a Functional Ingredient in Food and Gut Health. Journal of Food and Nutrition Research. 2019; 7(3):213-223. doi: 10.12691/jfnr-7-3-6

Abstract

Probiotics are live microbes which serve as excellent functional food ingredients, to improve human health. They provide essential metabolites with dietary and therapeutic characteristics which confers numerous health benefits. They ensure a proper maintenance of the gut health through complex interactions across the gut-brain axis. The probiotics enter into the body through food. Probiotics can exist naturally or be infused in food. Food products containing probiotics are viable modes for a healthy gut. Understanding the mechanism of action of the probiotic strains and their interaction with the gut microflora is absolutely necessary. This review elaborates on the applications of probiotics in food .It also describes the possible mechanism of action and its clinical significance.

Keywords:
probiotics food formulations gastroenteritis clinical implications

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Syngai, G.G., Gopi, R., Bharali, R., Dey, S., Alagu Lakshmanan, G.M. and Ahmed, G. “Probiotics - the versatile functional food ingredients”, Journal of Food Science and Technology, 53. 921-933. 2016.
[2]	Kechagia, M., Basoulis, D., Konstantopoulou, S., Dimitriadi, D., Gyftopoulou, K., Skarmoutsou, N. and Fakiri, E.M. “Health benefits of probiotics: a review”. ISRN Nutr Article ID 481651. 2013.
[3]	FAO/WHO. “Report of a Joint FAO/WHO Expert Consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live LAB”. Food and Agriculture Organization of the United Nations World Health Organization. 2001.
[4]	Tannis, A. “Probiotic rescue: how you can use probiotics to fight cholesterol, cancer superbugs, digestive complaints and more”, John Wiley & Sons Canada, Ltd P: 269. 2008.
[5]	Naidu, A., S., Bidlack, W. and Clemens, R. “Probiotic spectra of lactic acid bacteria (LAB)”, Critical Review in Food Science and Nutrition, 39, 13-126. 1999.
[6]	Sanders, M. “In Probiotics, Prebiotics and new Foods”: Rome, Italy, pp. 27-30. 2001
[7]	Granato, D., Branco, G. F., Nazzaro, F., Cruz, A. G. and Faria, J. A. F. “Functional Foods and Non-dairy Probiotic Food Development: Trends, Concepts, and Products”, Comprehensive Reviews in Food Science and Food Safety, 9, 292-302. 2010.
[8]	Kumar, B. V., Vijayendra, S.V.N. and Reddy, O.V.S. “Trends in dairy and non-dairy probiotic products - a review”, Journal of Food Science and Technology, 52, 6112-6124. 2015.
[9]	Saarela, M., Virkajarvi, I., Alakomi, H. L., Sigvart-Mattila, P. and Matto, J. “Stability and Functionality of freeze-dried Probiotic Bifidobacterium Cells during Storage in Juice and Milk”, International Dairy Journal, 16, 1477-1482. 2006.
[10]	Stephenie, W., Kabeir, B., Shuhaimi, M., Rosfarizan, M. and Yazid, “A. Growth Optimization of a Probiotic Candidate, Bifidobacterium pseudocatenulatum G4, in Milk Medium Using Response Surface Methodology”. Biotechnology and Bioprocess Engineering, 12, 106-113. 2007.
[11]	Makelainen, H., Forssten, S., Olli, K., Granlund, L., Rautonen, N. and Ouwehand, A. “Probiotic Lactobacilli in a Semi-Soft Cheese Survive in the Simulated Human Gastrointestinal Tract”, International dairy journal, 19, 675-683. 2009.
[12]	Mortazavian, A. M., Mohammadi, R. and Sohrabvandi, S. “Delivery of probiotic microorganisms into gastrointestinal tract by food products”. In T Brzozowski (ed). New advances in the basic and clinical gastroenterology, Rijeka, Croatia: In Tech, 566. 2012.
[13]	Kailasapathy, K. and Masondole L. “Survival of free and microencapsulated Lactobacillus acidophilus and Bifidobacterium lactis and their effect on texture of feta cheese”, Australian Journal of Dairy Technology, 60, 252-258. 2005.
[14]	Shah, N. “Probiotic Bacteria: Selective Enumeration and Survival in Dairy Foods”. Journal dairy science, 83, 894-907. 2000.
[15]	Supavititpatana, P., Wirjantoro, T. I., Apichartsrangkoon, A. and Raviyan, P. “Addition of gelatin enhanced gelation of corn-milk yogurt”, Food Chemestry, 106, 211-216. 2008.
[16]	Mortazavian, A.M., Azizi, A., Ehsani, M.R., Razavi, S.H., Mousavi, S.M., Sohrabvandi, S. and Reinheimer, J.A. “Survival of encapsulated probiotic bacteria in Iranian yogurt drink Doogh after the product exposure to simulated gastrointestinal conditions”, Milchwissenschaft, 63, 427-429. 2008.
[17]	Salovaara, H. and Ganzle, M. “Lactic Acid Bacteria in Cereal-based Products. In: Lahtinen S, Salminen S, Ouwehand A, WrightA. Lactic Acid Bacteria: Microbiological and Functional Aspects. London: CRC Press. pp. 227: 245. 2011.
[18]	Martenson, O., Oste, R. and Holst, O. “The effect of yoghurt culture on the survival of probiotic bacteria in oat-based, non-dairy products”. Food Research International, 35, 775-784. 2002.
[19]	Amor, M.S. and Mayo, B. “Selection criteria for lactic acid bacteria to be used as functional starter cultures in dry sausage production: an update”, Meat Science, 76.138-146. 2007.
[20]	Sidira, M., Karapetsas, A., Galanis, A., Kanellaki, M. and Kourkoutas Y. “Effective survival of immobilizedLactobacillus casei during ripening and heat treatment of probiotic dry-fermented sausages and investigation of the microbial dynamics”, Meat Science, 96, 948-955. 2014.
[21]	Mousavi, Z., Mousavi, S., Razavi, S., Emam-Djomeh, Z. and Kiani, H. “Fermentation of Pomegranate Juice by Probiotic Lactic Acid Bacteria”, World journal of microbiology and biotechnology, 27. 123-128. 2011.
[22]	Ana, L. F. P., Tatiane, C. and Sueli, R. “Probiotic beverage from cashew apple juice fermented with Lactobacillus casei”, Food Research International, 44, 1276-1283. 2011.
[23]	Wang, C. Y., Ng, C. C., Su, H., Tzeng, W. S. and Shyu, Y. T. “Probiotic Potential of Noni Juice Fermented with Lactic Acid Bacteria and Bifidobacteria”, International Journal of Food Sciences and Nutrition, 60. 98-106. 2009.
[24]	Yoon, K. Y., Woodams, E. E. and Hang, Y. D. “Probiotication of tomato juice by lactic acid bacteria”, Journal of Microbiology, 42. 315-318, 2004.
[25]	Mercenier, A., Pavan, S. and Pot, B. “Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects”, Current Pharmaceutical Design, 8. 99-110. 2002.
[26]	Song, D., Ibrahim, S., & Hayek, S. “Recent Application of Probiotics in Food and Agricultural Science”. Probiotics. 2012.
[27]	Cerbo, A.D. and Palmieri, B. “The market of probiotics”. Pakistan Journal of Pharmaceutical Sciences, 28. 2199-2206. 2015.
[28]	Sharp, M. D., McMahon, D. J. and Broadbent, J. R. “Comparative evaluation of yogurt and low fat Cheddar cheese as delivery media for probiotic Lactobacillus casei”, Journal of Food Science, 73. 375-377. 2008.
[29]	Homayouni, A., Azizi, A., Ehsani, M. R., Yarmand, M. S. and Razavi, S. H. “ Effect of microencapsulation and resistant starch on the probiotic survival and sensory properties of synbiotic ice cream”, Food Chemistry, 111. 50-55. 2008.
[30]	David, R. S. “The Safety of Probiotics”, Clinical Infectious Diseases, 46, 104-11. 2008.
[31]	Sekirov, I., Russell, S.L.L. and Antunes, CM. Finlay BB. “Gut Microbiota in Health and Disease”, Physiological Reviews, 90. 859-904. 2010.
[32]	Collado, M.C., Isolauri, E., Salminen, S. and Sanz, Y. “The Impact of Probiotic on Gut Health, Current Drug Metabolism, 10. 68-78. 2009.
[33]	Burkholder, K.M. and Bhunia, A.K. “Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG”. Gut Pathogen, 1. 14. 2009.
[34]	Sears, C.L. “Molecular physiology and pathophysiology of tight junctions V. Assault of the tight junction by enteric pathogens”, Americaan Journal of Physiology- Gastrointestinal Liver Physiology, 279. 1129-1134. 2000.
[35]	Collado, M.C., Meriluoto, J. and Salminen, S. “Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus”, Letters in Applied Microbiology, 45. 454-460. 2007.
[36]	Sherman, P.M., Ossa, J.C. and Johnson-Henry, K. “Unraveling mechanisms of action of probiotics”. Nutrition in Clinical Practice, 24.10-14. 2009.
[37]	Lobo, V., Patil, A., Phatak, A. and Chandra, N. “Free radicals, antioxidants and functional foods: impact on human health”, Pharmacognosy Reviews, 4. 118–126. 2010.
[38]	Gomes, B.C., Rodrigues, M.R., Winkelströter, L.K., Nomizo, A. and de Martinis, E.C. “In vitro evaluation of the probiotic potential of bacteriocin producer Lactobacillus sakei 1”, Journal of Food Protection, 75, 1083-1089. 2012.
[39]	Gudina, E.J., Teixeira, J.A. and Rodrigues, L.R. “Isolation and functional characterization of a biosurfactant produced by Lactobacillus paracasei”, Colloids and Surfaces B: Biointerfaces, 76. 298-304. 2010.
[40]	Marianelli, C., Cifani, N. and Pasquali, P. “Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp Enterica serovar typhimurium 1344 in a common medium under different environmental conditions”, Research in Microbiology, 161, 673-680. 2010.
[41]	Schellenberg, J.J., Dumonceaux, T.J., Hill, J.E., Kimani, J., Jaoko, W., Wachihi, C., Mungai. J.N., Lane, M., Fowke, K.R., Ball, T.B. and Plummer, F.A. “Selection, phenotyping and identification of acid and hydrogen peroxide producing bacteria from vaginal samples of canadian and east African women”, PLoS One, 7: e41217. 2012
[42]	Bermudez-Brito, M., Plaza-Diaz, J., Munoz-Quezada, S., Gomez-Llorente, C. and Gil, A. Probiotic mechanisms of action. Annals of Nutrition and Metabolism, 61. 160-174. 2012.
[43]	Hardy, H., Harris, J., Lyon, E., Beal, J. and Foey, A.D. “Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology”, Nutrients, 5. 1869-1912. 2013.
[44]	Mohanty, D., Jena, R., Choudhury, R.K., Pattnaik, R., Mohapatra, S. and Saini, M.R. “Milk Derived Antimicrobial Bioactive Peptides: A Review”, International Journal of Food Properties, 19. 837-846. 2016.
[45]	Huang, Y., Huang, J. and Chen, Y. “Alpha-helical cationic antimicrobial peptides: relationships of structure and function”, Protein Cell, 1.143-152. 2010.
[46]	Ramiah, K., Van Reenen, C.A. and Dicks, L.M. “Surface-bound proteins of Lactobacillus plantarum 423 that contribute to adhesion of Caco-2 cells and their role in competitive exclusion and displacement of Clostridium sporogenes and Enterococcus faecalis”, Research in Microbiology, 159, 470-475. 2008.
[47]	Pretzer, G., Snel, J. and Molenaar, D. “Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum”, Journal of Bacteriology, 187. 6128-6136. 2005.
[48]	Resta-Lenert, S. and Barrett, K.E. “Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli EIEC”, Gut, 52. 988-997. 2003.
[49]	Marco, M.L., Pavan, S. and Kleerebezem, M. “Towards understanding molecular modes of probiotic action”, Current opinion in biotechnology, 17. 204-210. 2006.
[50]	Hojo, K., Nagaoka, S., Murata, S., Taketomo, N., Ohshima, T. and Maeda, N. “Reduction of vitamin K concentration by salivary Bifidobacterium strains and their possible nutritional competition with Porphyromonas gingivalis”, Journal of Applied Microbiology, 103.1969-1974. 2007.
[51]	Ohland, C.L. & MacNaughton, W.K. “Probiotic bacteria and intestinal epithelial barrier function”, American Journal of Physiology: Gastrointestinal and Liver Physiology, 298. 807-819. 2010.
[52]	Guttman, J.A., Li, Y., Wickham, M.E., Deng, W., Vogl, A.W. and Finlay, B.B. “Attaching and effacing pathogen-induced tight junction disruption in vivo”, Cellular Microbiology, 8. 634-645. 2006.
[53]	Mennigen, R., Nolte, K., Rijcken, E., Utech, M., Loeffler, B., Senninger, N. and Bruewer, M. “Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis”. American Journal of Physiology-Gastrointestinal and Liver Physiology, 296. 1140-1149. 2009.
[54]	Wehkamp, J., Harder, J. and Wehkamp, K. “NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium”, Infection and Immunity, 72. 5750-5758. 2004.
[55]	Oelschlaeger, T.A. “Mechanisms of probiotic actions - A review. International Journal of Medical Microbiology, 300. 57-62. 2010.
[56]	Lin, P.W., Nasr, T.R. and Berardinelli, A.J. “The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut”, Pediatric Research, 64. 511-516. 2008.
[57]	Bron, P.A., Van Baarlen, P. and Kleerebezem, M. “Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa”, Nature Reviews Microbiology, 10. 66-78. 2012.
[58]	Yaqoob, P. “Ageing, immunity and influenza: a role for probiotics?”, Proceedings of the Nutrition Society, 73. 309-317. 2014.
[59]	Vimal, Y. and Dileep, P. “Some aspects of probiotic”, Indian Journal of Microbiology, 46. 1-7. 2006.
[60]	Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T.A., Stange, E.F. and Fellermann, K. “Induction of humanβ-defensin 2 by the probioticEscherichia coli Nissle 1917 is mediated through flagellin”, Infection and Immunity, 75, 2399-2407. 2007.
[61]	Saran, S. “Use of fermented foods to combat stunting and failure to thrive”, Nutrition, 18. 393-396. 2002.
[62]	Gopal, P.K., Prasad, J., Smart, J. and Gill, H.S. “In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli”, International Journal of Food Microbiology, 67. 207-216. 2001.
[63]	Heineman, J., Bubenik, S., McClave, S. and Martindale, R. “Fighting fire with fire: is it time touse probiotics to manage pathogenic bacterial diseases?”, Current Gastroenterology Reports, 14. 343-348. 2012.
[64]	Candela, M., Perna, F., Carnevali, P., Vitali, B., Ciati, R., Gionchetti, P., Rizzello, F., Campieri, M. and Brigidi, P. “Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production”, International Journal of Food Microbiology, 125. 286-292. 2008.
[65]	Rostagno, M.H., Wesley, I.V., Trampel, D.W. and Hurd, H.S. “Salmonella prevalence in marketage turkeys on-farm and at slaughter”, Poultry Science, 85. 1838-1842. 2006.
[66]	Thirabunyanon, M., Boonprasom, P. and Niamsup, P. “Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on anti-proliferation of colon cancer cells”, Biotechnology Letters, 31, 571-576. 2009.
[67]	Ruszczynski, M., Radzikowski, A. and Szajewska, H. “Clinical trial:effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children”, Alimentary Pharmacology & Therapeutics, 28. 154-161. 2008.
[68]	Fontana, L., Bermudez-Brito, M., Plaza-Diaz, J., Munoz-Quezada, S. and Gil, A. “Sources, isolation, characterization and evaluation of probiotics”, British Journal of Nutrition, 109. 35-50. 2013.
[69]	McFarland, L.V. “Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections”, Anaerobe, 15. 274-280. 2009.
[70]	Hickson, M., D’Souza, A.L., Muthu, N., Rogers, T.R., Want, S. and Rajkumar, C. “Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial”, BMJ, 335. 380. 2007.
[71]	Gaon, D., Garmendia, C., Murrielo, N.O., de Cucco Games, A., Cerchio, A., Quintas, R., Gonz´ alez, S.N. and Oliver, G. “Effect of Lactobacillus strains (L.casei and L.acidophilus strains cereal) on bacterial overgrowth-related chronic diarrhea”, Medicina, 62. 159-163. 2002.
[72]	Miyazaki, Y., Kamiya, S., Hanawa, T., Fukuda, M., Kawakami, H., Takahashi, H. and Yokota, H. “Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli”, Journal of Infection and Chemotherapy, 16. 10-18. 2010.
[73]	Gascon, J. “Epidemiology, etiology and pathophysiology of traveler’s diarrhea”, Digestion, 73. 102-108. 2006.
[74]	McFarland, L.V. “Meta-analysis of probiotics for the prevention of traveler’s diarrhea”, Travel Medicine and Infectious Disease, 5. 97-105. 2007.
[75]	Guarino, A., Albano, F., Ashkenazi, S., Gendrel, D., Hoekstra, J.H., Shamir, R. and Szajewska, H. “European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary”, Journal of Pediatric Gastroenterology & Nutrition, 46. 619-621. 2008.
[76]	Fonden, R., Mogensen, G., Tanaka, R. and Salminen, S. “Culture-containing dairy products—effect on intestinal microflora, human nutrition and health: current knowledge and future perspectives”, Bulletin of the International Dairy Federation, 352. 1-30. 2000.
[77]	Marteau, P., de Vrese, M., Cellier, C. and Schrezenmeir, J. “Protection from gastrointestinal diseases using probiotics”, The American Journal of Clinical Nutrition, 73. 430-436. 2001.
[78]	Preidis, G.A., Hill, C., Guerrant, R.L., Ramakrishna, B.S., Tannock, G.W. and Versalovic, J. “Probiotics, enteric and diarrheal diseases, and global health”, Gastroenterology, 140. 8-14. 2010.
[79]	Aggett, P.J., Agostoni, C., Axelsson, I., Braegger, C., Goulet, O., Koletzko, B., Michaelsen, K.F., Rigo, J., Shamir, R., Szajewska, H., Turck, D. and Weaver, L.T. “ Probiotic bacteria in dietetic products for infants: A Commentary by the ESPGHAN Committee on Nutrition”, Journal of Pediatric Gastroenterology & Nutrition, 38, 365-374. 2004.
[80]	Baryshnikova, N.V. “Helicobacter pylori-associated gastroenterological diseases: genetic features and probiotic treatment”, Beneficial Microbes, 3. 157-161. 2012.
[81]	Sullivan, A. and Nord, C.E. “The place of probiotics in human intestinal infections”, International Journal of Antimicrobial Agents, 20. 313-319.2002.
[82]	Myllyluoma, E., Kajander, K., Mikkola, H., Kyronpalo, S., Rasmussen, M., Kankuri, E., Sipponen, P., Vapaatalo, H. and Korpela, R. “Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection”, Digestive and Liver Disease, 39. 516-523. 2007.
[83]	Hedin, C., Whelan, K. and Lindsay, J.O. “Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials”, Proceedings of the Nutrition Society, 66. 307-315. 2007.
[84]	Thomson, A.B., Chopra, A., Clandinin, M.T. and Freeman, H. “Recent advances in small bowel diseases: Part I”, World Journal of Gastroenterology, 18. 3336-3352. 2012.
[85]	Floch, M. H. “Probiotic therapy for ulcerative colitis”, Journal of Clinical Gastroenterology, 44. 237-238. 2010.
[86]	Fujimori, S., Tatsuguchi, A., Gudis, K., Kishida, T., Mitsui, K. and Ehara, A. “High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease”, Nature Reviews Gastroenterology & Hepatology, 22. 1199-1204. 2007.
[87]	Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K.M. and Brigidi, P. “Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial”, Gastroenterology, 124. 1202-1209. 2003.
[88]	Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D. and Bazzocchi, G. “Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial”, Gastroenterology, 119. 305-309. 2000.
[89]	Collins, S.M., Denou, E., Verdu, E.F. and Bercik, P. “The putative role of the intestinal microbiota in the irritable bowel syndrome”, Digestive and Liver Disease, 41. 850-853. 2009.
[90]	Kruis, W., Chrubasik, S. and Boehm, S. “A double-blind placebocontrolled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome”, International Journal of Colorectal Disease, 27: 467-474. 2012.
[91]	Rogers, N.J. and Mousa, S.A. “The shortcomings of clinical trials assessing the efficacy of probiotics in irritable bowel syndrome”, Journal of Alternative and Complementary Medicine, 18. 112-119. 2012.
[92]	Mohanty, D.P., Mohapatra. S., Misra, S. and Sahu, P.S. “Milk derived bioactive peptides and their impact on human health – A review”, Saudi Journal of Biological Sciences, 23, 577-583. 2016.
[93]	Mohanty, D.P., Mohapatra. S., Misra, S. and Sahu, P.S. “Prebiotics and synbiotics: Recent concepts in nutrition”, Food Bioscience, 26.152-160. 2018.